News
Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback